Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis

Veterinary Pathology

Volumn 42, Issue 6, 2005, Pages 805-811

  Hershey, A E ^a,c   Dubielzig, R R ^a   Padilla, M L ^a   Helfand, S C ^a,b,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c Integrative Veterinary Oncology   (United States)

^d OREGON STATE UNIVERSITY   (United States)

Author keywords

Cats; Fibrosarcoma; Immunohistochemistry; p53; Tumor suppressor genes

Indexed keywords

PROTEIN P53;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; SARCOMA; VACCINATION;

ANIMALS; CAT DISEASES; CATS; IMMUNOHISTOCHEMISTRY; SARCOMA; TUMOR SUPPRESSOR PROTEIN P53; VACCINATION;

FELIDAE; MURINAE; ORYCTOLAGUS CUNICULUS;

EID: 28144455426     PISSN: 03009858     EISSN: 03009858     Source Type: Journal    
DOI: 10.1354/vp.42-6-805     Document Type: Article

References (39)

1. Brandt-Rauf PW, DeVivo I, Dykes DC, Pincus MR: Conformational effects of selected cancer-related amino acid substitutions in the p53 protein. J Biomol Struct Dyn 10:253-264, 1992
2. Dobashi Y, Sakamoto A, Sugimura H, Mernyei M, Mori M, Oyama T, Machinami R: Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 17:375-381, 1993
3. Doddy FD, Glickman LT, Glickman NW, Janovitz EB: Feline fibrosarcomas at vaccination and non-vaccination sites. J Comp Pathol 114:165-174, 1996
4. Elledge RM, Clark GM, Fuqua SAW, Yu Y-Y, Allred DC: P53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res 54:3752-3757, 1994
5. Esplin DG, McGill LD, Meininger AC, Wilson SR: Postvaccination sarcomas in cats. J Am Vet Med Assoc 202:1245-1247, 1993
6. Flamini G, Curigliano G, Ratto C, Astone A, Feretti G, Nucera P, Sofo L, Sgambato A, Boninsegna A, Crucitti F, Cittadini A: Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis. Eur J Cancer 32A:802-806, 1996
7. Flamini G, Magalini S, Curigliano G, Nanni G, Boninsegna A, Agnes S, Faticato D, Castagneto M, Cittadini A: Immunohistochemical analysis of p53 protein in transplant recipients with Kaposi's sarcoma. J Cancer Res Clin Oncol 123:240-242, 1997
8. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM, Miller YE: Widely dispersed p53 mutation in respiratory epithelium: a novel mechanism for field carcinogenesis. J Clin Invest 100:2133-2137, 1997
9. Gannon JV, Greaves R, Iggo R, Lane DP: Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595-1602, 1990
10. Gannon JV, Lane DP: Protein synthesis required to anchor a mutant p53 which is temperature-sensitive for nuclear transport. Nature (Lond) 349:802-806, 1991
11. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994
12. Halevy O, Michalovitz D, Oren M: Different tumor-derived p53 mutants exhibit distinct biological activities. Science 250:113-116, 1990
13. Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88:1442-1455, 1996
14. Harris CC, Hollstein M: Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329:1318-1327, 1993
15. Hershey AE, Sorenmo KU, Hendrick MJ, Shofer F, Vail DM: Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996). J Am Vet Med Assoc 216:58-61, 2000
16. Hollstein M, Sidransky D, Vogelstein B, Harris CC: P53 mutations in human cancers. Science 253:49-53, 1991
17. Isola J, Visakorpi T, Holli K, Kallioniemi OP: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109-1114, 1992
18. Kanjilal S, Banerji N, Fifer A, Wood C, Klausner JS, Kapur V: p53 tumor suppressor gene alterations in vaccine-associated feline sarcoma. Proc Annu Vet Cancer Soc Conf 19:48, 1999
19. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H: Nuclear immunoreaction of p53 protein in soft tissue sarcomas, a possible prognostic factor. Cancer 73:2499-2505, 1994
20. Li X, Tsuji T, Wen S, Sobban F, Wang Z, Shinozaki F: Cytoplasmic expression of p53 protein and its morphological features in salivary gland lesions. J Oral Pathol Med 24:201-205, 1995
21. Macy D: Vaccine associated sarcomas. Proc Annu Vet Med Forum Am Coll Vet Intern Med 12:854-856, 1994
22. Mayr B, Heczko U, Schellander K, Schleger W, Reifinger M: Sequence of an exon of the feline p53 gene-mutation in a lymphosarcoma. Br Vet J 149:387-390, 1993
23. Mayr B, Schaffner G, Kurzbauer R, Reifinger M, Schellander K: Sequence of an exon of tumour suppressor gene-a comparative study in domestic animals: mutation in a feline solid mammary carcinoma. Br Vet J 151:325-329, 1995
24. Mayr B, Schaffner G, Kurzbauer R, Schneider A, Reifinger M, Loupal G: Mutations in tumour suppressor gene p53 in two feline fibrosarcomas. Br Vet J 151:707-713, 1995
25. Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, Yamamuro T, Lampkin B, Koeffler HP: Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50:7950-7954, 1990
26. Moll UM, LaQuaglia M, Benard J, Riou G: Wildtype p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92:4407-4411, 1995
27. Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262-7266, 1992
28. Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ: DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci USA 93:15209-15214, 1996
29. Poirier VJ, Thamm DH, Kurzman ID, Jeglum KA, Chun R, Obradovich JE, O'Brien M, Fred RM 3rd, Phillips BS, Vail DM: Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats. J Vet Intern Med 16:726-31, 2002
30. Raycroft L, Schmidt JR, Yoas K, Hao M, Lozano G: Analysis of p53 mutants for transcriptional activity. Mol Cell Biol 11:6067-6074, 1992
31. Sagartz JE, Bodley WL, Gamblin RM, Couto CG, Tierney LA, Capen CC: P53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet Pathol 33:213-221, 1996
32. Sozzi G, Miozzo M, Tagliabue E, Calderone C, Lombardi L, Pilotti S, Pastorino U, Pierotti MA, Della Porta G: Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 51:400-404, 1991
33. Stenmark-Askmalm M, Stal O, Sullivan S, Ferraud L, Sun XF, Carstensen J, Nordenskjold B: Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer. Eur J Cancer 32A:175-180, 1994
34. Sun XF, Carstensen JM, Zhang H, Arbman G, Nordenskjold B: Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas. Eur J Cancer 32A:1963-1967, 1996
35. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, Nordenskjold B: Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinomas. Lancet 340:1369-1373, 1992
36. Sun XF, Zhang H, Carstensen JM, Jansson A, Nordenskjold B: Heat shock protein 72/73 in relation to cytoplasmic p53 expression and prognosis in colorectal adenocarcinomas. Int J Cancer 74:600-604, 1997
37. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, et al.: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845-855, 1992
38. Williams L, Zinggeler J, Klausner J, Kanjilal S: Field Cancerization. Vet Cancer Soc Newsletter 22:8-9, Winter 1998-1999
39. Vogelstein B, Kinzler KW: P53 function and dysfunction. Cell 70:523-526, 1992